Due to the high potential for COVID-19 transmission even in asymptomatic individuals, Rastogi et al. [41] wanted to investigate the effect of oral cholecalciferol supplementation on CRP negativation at day 21 in asymptomatic or mildly symptomatic individuals with low (<20 ng/mL) calcifediol levels. This evidence concerns the gene CRP and COVID-19.